2-In-1 Inhaler Reduces Asthma Attacks In Children By 45% Shows New Study

2-In-1 Inhaler Reduces Asthma Attacks In Children By 45% Shows New Study

2-In-1 Inhaler Reduces Asthma Attacks In Children By 45% Shows New Study By George Dagerotip For Unsplash+ New findings could reshape the treatment for an estimated 113 million children worldwide who have asthma, following this side-by-side comparison of two types of asthma inhalers. In the first randomized controlled trial to investigate the use of a combination inhaler as the sole reliever for children aged 5 to 15, an international team found the 2-in-1 treatment to be more effective than salbutamol—the current standard for asthma symptom relief in children. The results show that using an inhaler that combines 2 treatments—the inhaled corticosteroid (ICS) budesonide and the fast-acting bronchodilator formoterol—reduced children’s asthma attacks by an average of 45%, compared to the widely-used salbutamol inhaler. Asthma attacks in children may be life-threatening and reducing their frequency and severity should be a public health priority. The 2-in-1 budesonide-formoterol inhaler is wide…